| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP22 TBC1D4 SRGAP3 TBC1D3I TBC1D3G IQGAP3 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PLEKHG6 ARHGEF1 SIPA1L1 | 9.58e-09 | 279 | 242 | 18 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | OBSCN ARHGAP22 TBC1D4 SRGAP3 TBC1D3I TBC1D3G IQGAP3 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PLEKHG6 ARHGEF1 SIPA1L1 | 1.46e-05 | 507 | 242 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | OBSCN ARHGAP22 TBC1D4 SRGAP3 TBC1D3I TBC1D3G IQGAP3 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PLEKHG6 ARHGEF1 SIPA1L1 | 1.46e-05 | 507 | 242 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK17 SPEG OBSCN MAP3K5 FCSK BMPR2 SHPK PI4KA NADK KDR NRBP1 MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 PRKDC MAP3K21 CSNK2A3 | 1.88e-05 | 709 | 242 | 23 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | CDK17 SPEG OBSCN TRRAP MAP3K5 FCSK BMPR2 SHPK PI4KA NADK KDR NRBP1 MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 PRKDC MAP3K21 CSNK2A3 | 2.07e-05 | 764 | 242 | 24 | GO:0016301 |
| GeneOntologyMolecularFunction | enzyme activator activity | CLPX ARHGAP22 TBC1D4 PSME4 SRGAP3 TBC1D3I TBC1D3G IQGAP3 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D PARP8 TBC1D3C TBC1D3B PLEKHG6 ARHGEF1 SIPA1L1 | 5.31e-05 | 656 | 242 | 21 | GO:0008047 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK17 SPEG OBSCN TRRAP MAP3K5 FCSK BMPR2 SHPK PI4KA NADK KDR ART5 NRBP1 PARP8 MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 PRKDC MAP3K21 CSNK2A3 | 7.65e-05 | 938 | 242 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK17 SPEG OBSCN MAP3K5 BMPR2 KDR NRBP1 MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 PRKDC MAP3K21 CSNK2A3 | 1.40e-04 | 600 | 242 | 19 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK17 SPEG OBSCN MAP3K5 BMPR2 NRBP1 MINK1 MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 PRKDC MAP3K21 CSNK2A3 | 3.78e-04 | 446 | 242 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK17 SPEG OBSCN MAP3K5 MINK1 MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 PRKDC MAP3K21 CSNK2A3 | 5.15e-04 | 363 | 242 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | growth factor binding | 6.45e-04 | 156 | 242 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | 5'-3' RNA exonuclease activity | 8.64e-04 | 4 | 242 | 2 | GO:0004534 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 8.76e-04 | 16 | 242 | 3 | GO:0043138 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | ARHGAP22 TBC1D4 TBC1D3I TBC1D3G SLC27A4 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 | 2.27e-12 | 109 | 239 | 15 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | ARHGAP22 TBC1D4 TBC1D3I TBC1D3G SLC27A4 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 SNX18 | 2.81e-08 | 244 | 239 | 16 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | ARHGAP22 TBC1D4 TBC1D3I TBC1D3G SLC27A4 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 SNX18 | 2.02e-06 | 335 | 239 | 16 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | MAP3K5 ARHGAP22 TBC1D4 TBC1D3I TBC1D3G SLC27A4 TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SIPA1L1 SNX18 ROBO1 CTSD | 6.24e-06 | 499 | 239 | 19 | GO:0051345 |
| GeneOntologyBiologicalProcess | mesenchyme migration | 1.51e-05 | 5 | 239 | 3 | GO:0090131 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDH23 HMCN2 PCDHGB5 PCDHB2 PCDHB18P CELSR2 ROBO1 PCDH8 CDH9 CDH16 | 6.81e-05 | 187 | 239 | 10 | GO:0007156 |
| HumanPheno | Congenital hip dislocation | HDAC4 ACTA1 SLC5A7 ITGA7 RYR1 ECEL1 COL6A1 UBE3B OBSL1 IARS2 | 1.23e-06 | 84 | 87 | 10 | HP:0001374 |
| Domain | TBC | TBC1D4 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.98e-11 | 49 | 236 | 11 | SM00164 |
| Domain | RabGAP-TBC | TBC1D4 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 4.96e-11 | 53 | 236 | 11 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D4 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 7.62e-11 | 55 | 236 | 11 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D4 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 7.62e-11 | 55 | 236 | 11 | PS50086 |
| Domain | Alpha_tubulin | 2.98e-06 | 9 | 236 | 4 | IPR002452 | |
| Domain | Kinase-like_dom | CDK17 SPEG OBSCN TRRAP MAP3K5 BMPR2 PI4KA KDR NRBP1 MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 PRKDC MAP3K21 CSNK2A3 | 5.72e-06 | 542 | 236 | 21 | IPR011009 |
| Domain | Prot_kinase_dom | CDK17 SPEG OBSCN MAP3K5 BMPR2 KDR NRBP1 MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 MAP3K21 CSNK2A3 | 5.29e-05 | 489 | 236 | 18 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK17 SPEG OBSCN MAP3K5 BMPR2 KDR NRBP1 MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 MAP3K21 CSNK2A3 | 5.88e-05 | 493 | 236 | 18 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | CDK17 SPEG OBSCN MAP3K5 BMPR2 KDR MINK1 ROR2 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 MAP3K21 CSNK2A3 | 7.94e-05 | 459 | 236 | 17 | PS00107 |
| Domain | Protein_kinase_ATP_BS | CDK17 SPEG OBSCN MAP3K5 BMPR2 KDR MINK1 TEK HIPK3 MAP4K5 CSNK2A1 PRKAA1 ROS1 MAP3K21 CSNK2A3 | 1.01e-04 | 379 | 236 | 15 | IPR017441 |
| Domain | - | 1.03e-04 | 20 | 236 | 4 | 3.30.1330.20 | |
| Domain | ACTINS_1 | 1.06e-04 | 8 | 236 | 3 | PS00406 | |
| Domain | - | 1.26e-04 | 21 | 236 | 4 | 1.10.287.600 | |
| Domain | Cadherin | 1.28e-04 | 118 | 236 | 8 | IPR002126 | |
| Domain | Tubulin_C | 1.52e-04 | 22 | 236 | 4 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.52e-04 | 22 | 236 | 4 | IPR018316 | |
| Domain | - | 1.52e-04 | 22 | 236 | 4 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.52e-04 | 22 | 236 | 4 | SM00865 | |
| Domain | Tub_FtsZ_C | 1.82e-04 | 23 | 236 | 4 | IPR008280 | |
| Domain | Tubulin_C | 1.82e-04 | 23 | 236 | 4 | IPR023123 | |
| Domain | TUBULIN | 1.82e-04 | 23 | 236 | 4 | PS00227 | |
| Domain | Tubulin | 1.82e-04 | 23 | 236 | 4 | IPR000217 | |
| Domain | Tubulin | 1.82e-04 | 23 | 236 | 4 | SM00864 | |
| Domain | Tubulin_CS | 1.82e-04 | 23 | 236 | 4 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 2.16e-04 | 24 | 236 | 4 | IPR003008 | |
| Domain | Tubulin | 2.16e-04 | 24 | 236 | 4 | PF00091 | |
| Domain | fn3 | 2.23e-04 | 162 | 236 | 9 | PF00041 | |
| Domain | FN3 | 2.28e-04 | 199 | 236 | 10 | PS50853 | |
| Domain | FN3_dom | 3.38e-04 | 209 | 236 | 10 | IPR003961 | |
| Domain | Cadherin_CS | 4.70e-04 | 109 | 236 | 7 | IPR020894 | |
| Domain | Striatin_N | 4.73e-04 | 3 | 236 | 2 | IPR013258 | |
| Domain | Striatin | 4.73e-04 | 3 | 236 | 2 | PF08232 | |
| Domain | CADHERIN_1 | 5.84e-04 | 113 | 236 | 7 | PS00232 | |
| Domain | Cadherin | 5.84e-04 | 113 | 236 | 7 | PF00028 | |
| Domain | FN3 | 5.91e-04 | 185 | 236 | 9 | SM00060 | |
| Domain | CADHERIN_2 | 6.16e-04 | 114 | 236 | 7 | PS50268 | |
| Domain | - | 6.16e-04 | 114 | 236 | 7 | 2.60.40.60 | |
| Domain | Ser/Thr_kinase_AS | CDK17 SPEG OBSCN MAP3K5 BMPR2 MINK1 MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 MAP3K21 CSNK2A3 | 6.45e-04 | 357 | 236 | 13 | IPR008271 |
| Domain | CA | 6.49e-04 | 115 | 236 | 7 | SM00112 | |
| Domain | S_TKc | CDK17 SPEG OBSCN MAP3K5 MINK1 TEK MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 MAP3K21 CSNK2A3 | 6.79e-04 | 359 | 236 | 13 | SM00220 |
| Domain | Cadherin-like | 6.83e-04 | 116 | 236 | 7 | IPR015919 | |
| Domain | PROTEIN_KINASE_ST | CDK17 SPEG OBSCN MAP3K5 BMPR2 MINK1 MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 MAP3K21 CSNK2A3 | 7.34e-04 | 362 | 236 | 13 | PS00108 |
| Domain | - | 9.88e-04 | 16 | 236 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 9.88e-04 | 16 | 236 | 3 | SM00146 | |
| Domain | Actin_CS | 9.88e-04 | 16 | 236 | 3 | IPR004001 | |
| Domain | Pkinase | CDK17 SPEG OBSCN MAP3K5 BMPR2 NRBP1 MINK1 MAPKAPK5 HIPK3 MAP4K5 CSNK2A1 PRKAA1 CSNK2A3 | 1.17e-03 | 381 | 236 | 13 | PF00069 |
| Domain | ACTINS_2 | 1.19e-03 | 17 | 236 | 3 | PS00432 | |
| Domain | PI3_PI4_kinase | 1.41e-03 | 18 | 236 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.41e-03 | 18 | 236 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.41e-03 | 18 | 236 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 1.41e-03 | 18 | 236 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.41e-03 | 18 | 236 | 3 | PS50290 | |
| Domain | Actin/actin-like_CS | 1.41e-03 | 18 | 236 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.66e-03 | 19 | 236 | 3 | PS01132 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | SOCS7 TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B | 5.24e-07 | 99 | 180 | 10 | M46448 |
| Pathway | BIOCARTA_MTA3_PATHWAY | 4.26e-06 | 20 | 180 | 5 | MM1383 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.97e-05 | 29 | 180 | 5 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 2.97e-05 | 29 | 180 | 5 | M27948 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 3.58e-05 | 98 | 180 | 8 | M776 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 4.89e-05 | 32 | 180 | 5 | M27491 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 5.37e-05 | 17 | 180 | 4 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 5.37e-05 | 17 | 180 | 4 | MM14731 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.84e-05 | 18 | 180 | 4 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.58e-05 | 19 | 180 | 4 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.58e-05 | 19 | 180 | 4 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.06e-04 | 20 | 180 | 4 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.06e-04 | 20 | 180 | 4 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.30e-04 | 21 | 180 | 4 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.30e-04 | 21 | 180 | 4 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.57e-04 | 22 | 180 | 4 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.88e-04 | 23 | 180 | 4 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.88e-04 | 23 | 180 | 4 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.88e-04 | 23 | 180 | 4 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.09e-04 | 43 | 180 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.24e-04 | 24 | 180 | 4 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.24e-04 | 24 | 180 | 4 | M47700 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.59e-04 | 45 | 180 | 5 | M47670 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.64e-04 | 25 | 180 | 4 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.64e-04 | 25 | 180 | 4 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 3.09e-04 | 26 | 180 | 4 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.09e-04 | 26 | 180 | 4 | M47672 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 3.59e-04 | 27 | 180 | 4 | MM15674 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.59e-04 | 27 | 180 | 4 | MM15549 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 4.14e-04 | 28 | 180 | 4 | M47898 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.66e-04 | 55 | 180 | 5 | M39613 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 6.99e-04 | 32 | 180 | 4 | MM14730 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 6.99e-04 | 32 | 180 | 4 | M29848 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 7.24e-04 | 56 | 180 | 5 | M2333 | |
| Pathway | REACTOME_KINESINS | 7.86e-04 | 57 | 180 | 5 | MM15714 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 7.88e-04 | 33 | 180 | 4 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 7.88e-04 | 33 | 180 | 4 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 9.88e-04 | 35 | 180 | 4 | M47774 | |
| Pathway | KEGG_RIBOFLAVIN_METABOLISM | 1.01e-03 | 16 | 180 | 3 | M6889 | |
| Pathway | REACTOME_KINESINS | 1.07e-03 | 61 | 180 | 5 | M977 | |
| Pathway | REACTOME_AGGREPHAGY | 1.10e-03 | 36 | 180 | 4 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.22e-03 | 37 | 180 | 4 | MM15102 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.61e-24 | 11 | 244 | 11 | 16863688 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 UBE4B SPEG OBSCN MED14 SPIRE1 PFAS EXTL3 ATG2A TRRAP RYR1 MAP3K5 NOD2 KMT2C FASN MGAT1 PSME4 PI4KA NADK ZC3H7B IQGAP3 BAHCC1 UBE3B CEP192 HUWE1 MLXIP MAPKAPK5 TRAK1 NHSL1 CELSR2 MEGF8 CTDP1 PDCD11 PRKDC | 5.43e-13 | 1105 | 244 | 34 | 35748872 |
| Pubmed | 1.41e-11 | 17 | 244 | 7 | 17360745 | ||
| Pubmed | 2.01e-09 | 9 | 244 | 5 | 21167302 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | SOCS7 TBC1D3G TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3D RNF222 TBC1D3B | 2.64e-09 | 74 | 244 | 9 | 16625196 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UBE4B MED14 PFAS CLPX TRRAP TUBA4A TUBA1B FASN TUBA1A AGL PUM3 ZC3H7B DNAH8 IQGAP3 NCAPD3 XRN2 HUWE1 SACM1L IARS2 RUVBL1 PDCD11 PRKDC | 6.61e-09 | 704 | 244 | 22 | 29955894 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBE4B USP11 PFAS SSR4 CLPX TRRAP TUBA4A BLM FASN PTPN12 TBC1D4 PSME4 PI4KA PPP1R37 PUM3 SLC27A4 KPNA3 GPI XRN2 CCDC22 SMCHD1 DHX57 HUWE1 RUVBL1 TFB1M MAP4K5 ARHGEF1 PDCD11 PRKDC CTSD CPSF3 | 8.07e-09 | 1353 | 244 | 31 | 29467282 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | CDK17 USP11 ACTA1 ACTA2 MTMR1 TUBA4A TUBA1B STRN TBC1D4 TUBA1A STRN3 XRN2 TUBA1C OBSL1 CEP192 HUWE1 RUVBL1 CSNK2A1 CIAO2B PRKDC | 3.23e-08 | 639 | 244 | 20 | 23443559 |
| Pubmed | 3.51e-08 | 6 | 244 | 4 | 3785200 | ||
| Pubmed | INTU UBE4B SPEG KLHL29 SRGAP3 KATNIP DOP1B WASHC2C WDR7 OBSL1 CEP192 MLXIP TRAK1 SACM1L MEGF8 SIPA1L1 | 3.73e-08 | 407 | 244 | 16 | 12693553 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 HDAC4 SPIRE1 MEX3C BMPR2 TBC1D4 PI4KA NADK DOP1B PARP8 MINK1 ROR2 CEP192 MLXIP TRAK1 NHSL1 FAM171A2 MEGF8 ARHGEF1 SIPA1L1 TMEM102 USP54 MAP3K21 | 5.29e-08 | 861 | 244 | 23 | 36931259 |
| Pubmed | 8.14e-08 | 7 | 244 | 4 | 36681692 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.62e-07 | 8 | 244 | 4 | 16148047 | |
| Pubmed | USP34 KIF1A USP11 PFAS TRRAP BLM FASN PUM3 XRN2 SMCHD1 TUBA1C PHRF1 DHX57 HUWE1 IARS2 CSNK2A1 PDCD11 PRKDC CPSF3 | 2.21e-07 | 653 | 244 | 19 | 22586326 | |
| Pubmed | USP34 PRAMEF7 OBSCN SPIRE1 SSR4 ZFYVE1 KMT2C PSME4 PI4KA PAN2 NADK AFF1 UMAD1 KPNA3 WASHC2C CEP192 HUWE1 PRAMEF8 AP3M1 AOPEP INTS13 ARHGEF1 SIPA1L1 PRKAA1 LRP2 | 2.22e-07 | 1084 | 244 | 25 | 11544199 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 2.90e-07 | 9 | 244 | 4 | 10556093 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 3.41e-07 | 3 | 244 | 3 | 7780165 | |
| Pubmed | USP11 TMEM165 PFAS TUBA4A FCSK PI4KA AGL ECEL1 IQGAP3 KPNA3 NCAPD3 TUBA1C OBSL1 HUWE1 SACM1L IARS2 TFB1M USP54 | 3.45e-07 | 606 | 244 | 18 | 36538041 | |
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 7.50e-07 | 11 | 244 | 4 | 23294842 | |
| Pubmed | KIF1A MED14 SPIRE1 TRRAP ALKBH5 BLM TUBA1B KMT2C STRN MGAT1 PI4KA IMP4 PUM3 ZC3H7B IQGAP3 KPNA3 NCAPD3 STRN3 TUBA1C MINK1 PHRF1 DHX57 MED15 SLC9A1 TFB1M INTS13 CSNK2A1 SIPA1L1 PDCD11 | 8.41e-07 | 1497 | 244 | 29 | 31527615 | |
| Pubmed | PFAS RAD54L2 SSR4 CLPX TUBA4A PSME4 ZC3H7B IQGAP3 SLC27A4 NCAPD3 XRN2 UBE3B MINK1 OBSL1 DHX57 SACM1L ARHGEF1 PRKAA1 | 9.45e-07 | 650 | 244 | 18 | 38777146 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | USP11 ACTA1 ACTA2 ACTC1 PFAS SSR4 CLPX TUBA4A TUBA1B FASN PSME4 TUBA1A AGL IQGAP3 SLC27A4 KPNA3 NCAPD3 XRN2 TUBA1C HUWE1 AP3M1 IARS2 RUVBL1 CIAO2B PRKDC CPSF3 | 9.82e-07 | 1257 | 244 | 26 | 37317656 |
| Pubmed | 1.11e-06 | 76 | 244 | 7 | 27542412 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.12e-06 | 12 | 244 | 4 | 15331610 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.36e-06 | 4 | 244 | 3 | 12359748 | |
| Pubmed | 1.36e-06 | 4 | 244 | 3 | 8406013 | ||
| Pubmed | 1.36e-06 | 4 | 244 | 3 | 18400243 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 HTRA1 TMEM165 CD109 WDR25 EXTL3 SSR4 ITGA7 BMPR2 PTPN12 TBC1D4 NADK ECEL1 TWSG1 COL6A1 NCAPD3 ROR2 SACM1L SNX14 RUVBL1 CELSR2 MEGF8 ROBO1 SMPD1 CTSD | 1.44e-06 | 1201 | 244 | 25 | 35696571 |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.61e-06 | 13 | 244 | 4 | 10908577 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | TUBA1B FASN TUBA1A PI4KA IQGAP3 NCAPD3 DDX60 SMCHD1 DHX57 PRKDC | 1.84e-06 | 202 | 244 | 10 | 33005030 |
| Pubmed | TUBA1B FASN AGL IQGAP3 CCDC157 NCAPD3 SMCHD1 PDCD11 PRKDC USP54 | 1.84e-06 | 202 | 244 | 10 | 24639526 | |
| Pubmed | 2.24e-06 | 14 | 244 | 4 | 21923909 | ||
| Pubmed | 2.24e-06 | 14 | 244 | 4 | 12486001 | ||
| Pubmed | 2.24e-06 | 14 | 244 | 4 | 17411366 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBE4B MED14 TRRAP BLM FASN TBC1D4 AFF1 NCAPD3 STRN3 XRN2 WASHC2C MINK1 PHRF1 HUWE1 CSNK2A1 SIPA1L1 CTDP1 PRKDC KDM4B | 2.75e-06 | 774 | 244 | 19 | 15302935 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PRAMEF7 ACTA2 OBSCN MED14 ACTC1 TUBA4A TUBA1B PSME4 TUBA1A PI4KA IQGAP3 STRN3 TUBA1C UBE3B PRAMEF8 PRKDC | 2.83e-06 | 564 | 244 | 16 | 21565611 |
| Pubmed | Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. | 3.04e-06 | 15 | 244 | 4 | 21606590 | |
| Pubmed | CDK17 HTRA1 ACTA1 MTMR1 SPIRE1 TUBA4A STRN FASN TUBA1A SRGAP3 PI4KA KPNA3 GPI STRN3 WDR7 TUBA1C MINK1 DHX57 AP3M1 SACM1L NHSL1 CSNK2A1 ARHGEF1 SIPA1L1 PRKAA1 USP54 UNC13A | 3.37e-06 | 1431 | 244 | 27 | 37142655 | |
| Pubmed | USP34 TUBA4A TUBA1B KMT2C PSME4 TUBA1A PI4KA RPRD2 SDHD TUBA1C CIAO2B PRKDC | 3.37e-06 | 322 | 244 | 12 | 26514267 | |
| Pubmed | 3.38e-06 | 5 | 244 | 3 | 12604796 | ||
| Pubmed | 3.38e-06 | 5 | 244 | 3 | 8471161 | ||
| Pubmed | CDK17 HDAC4 ACTA1 STRN TBC1D4 NADK STRN3 PARP8 CEP192 SIPA1L1 SNX18 PRKDC USP54 MAP3K21 | 3.81e-06 | 446 | 244 | 14 | 24255178 | |
| Pubmed | ACTA1 TRRAP TUBA1B FASN KIAA2012 DDX60 TUBA1C ROR2 RUVBL1 PDCD11 PRKDC | 4.00e-06 | 272 | 244 | 11 | 31010829 | |
| Pubmed | Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. | 4.03e-06 | 16 | 244 | 4 | 16873063 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 USP11 ACTC1 PFAS RAD54L2 ALKBH5 BLM STRN TBC1D4 TUBA1A PI4KA XRN2 WASHC2C OBSL1 CEP192 HUWE1 | 4.80e-06 | 588 | 244 | 16 | 38580884 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | USP11 ACTA2 ACTC1 CLPX KMT2C BAHCC1 KPNA3 NRBP1 COL6A1 MED15 PRKDC USP54 KDM4B | 5.54e-06 | 398 | 244 | 13 | 35016035 |
| Pubmed | 5.92e-06 | 37 | 244 | 5 | 9798653 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | USP11 STRN FASN USH2A FKBP1A KPNA3 NCAPD3 STRN3 PGGHG SMCHD1 DHX57 ITIH5 CSNK2A1 CIAO2B PDCD11 CTSD CPSF3 | 6.07e-06 | 670 | 244 | 17 | 22990118 |
| Pubmed | Thymosin beta 4 is dispensable for murine cardiac development and function. | 6.69e-06 | 18 | 244 | 4 | 22158707 | |
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 18613978 | ||
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 12090300 | ||
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 6.72e-06 | 6 | 244 | 3 | 22989508 | |
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 6.72e-06 | 6 | 244 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 6.72e-06 | 6 | 244 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 6.72e-06 | 6 | 244 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 6.72e-06 | 6 | 244 | 3 | 8661406 | |
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 23017337 | ||
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 6.72e-06 | 6 | 244 | 3 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 6.72e-06 | 6 | 244 | 3 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 6.72e-06 | 6 | 244 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 6.72e-06 | 6 | 244 | 3 | 11709093 | |
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 6.72e-06 | 6 | 244 | 3 | 7651436 | |
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 16327313 | ||
| Pubmed | 6.72e-06 | 6 | 244 | 3 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 6.72e-06 | 6 | 244 | 3 | 23875777 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | ACTA1 ACTA2 ACTC1 TUBA4A TUBA1B FASN TUBA1A GPI TUBA1C RUVBL1 PRKDC | 6.87e-06 | 288 | 244 | 11 | 31501420 |
| Pubmed | 7.30e-06 | 186 | 244 | 9 | 14744259 | ||
| Pubmed | 8.43e-06 | 19 | 244 | 4 | 15698476 | ||
| Pubmed | 8.43e-06 | 19 | 244 | 4 | 15691386 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | USP11 ACTA1 ACTA2 TUBA4A TUBA1A IQGAP3 SLC27A4 NCAPD3 XRN2 TUBA1C DHX57 HUWE1 PDCD11 PRKDC | 1.01e-05 | 486 | 244 | 14 | 30940648 |
| Pubmed | MTMR1 ITGA7 PI4KA PPP1R37 MINK1 ROR2 NHSL1 IARS2 CELSR2 FAM171A2 TFB1M MAP4K5 ROBO1 | 1.01e-05 | 421 | 244 | 13 | 36976175 | |
| Pubmed | USP34 ACTA2 CD109 EXTL3 SSR4 CLPX NOD2 FASN TUBA1A PUM3 SLC27A4 KPNA3 NCAPD3 XRN2 CCDC22 DDX60 TUBA1C DHX57 HUWE1 GFM2 SACM1L IARS2 SIPA1L1 CIAO2B PDCD11 PRKDC | 1.12e-05 | 1440 | 244 | 26 | 30833792 | |
| Pubmed | 1.16e-05 | 197 | 244 | 9 | 31620119 | ||
| Pubmed | 1.17e-05 | 7 | 244 | 3 | 22535526 | ||
| Pubmed | Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice. | 1.17e-05 | 7 | 244 | 3 | 19118250 | |
| Pubmed | Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. | 1.17e-05 | 7 | 244 | 3 | 11344305 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 1.17e-05 | 7 | 244 | 3 | 17504171 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 1.17e-05 | 7 | 244 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 1.17e-05 | 7 | 244 | 3 | 22640593 | |
| Pubmed | 1.17e-05 | 7 | 244 | 3 | 22465675 | ||
| Pubmed | Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. | 1.17e-05 | 7 | 244 | 3 | 15542434 | |
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.17e-05 | 7 | 244 | 3 | 9384381 | |
| Pubmed | 1.17e-05 | 7 | 244 | 3 | 30289203 | ||
| Pubmed | 1.17e-05 | 7 | 244 | 3 | 11146551 | ||
| Pubmed | Mekk3 is essential for early embryonic cardiovascular development. | 1.29e-05 | 21 | 244 | 4 | 10700190 | |
| Pubmed | CDK17 HDAC4 TUBA4A TBC1D4 TUBA1A NADK CSNK2A1 TMEM102 PRKDC CPSF3 | 1.44e-05 | 255 | 244 | 10 | 15324660 | |
| Pubmed | 1.50e-05 | 313 | 244 | 11 | 20800603 | ||
| Pubmed | 1.57e-05 | 22 | 244 | 4 | 28117675 | ||
| Pubmed | 1.57e-05 | 22 | 244 | 4 | 15103018 | ||
| Pubmed | TUBA4A TUBA1B TUBA1A TUBA1C HUWE1 RUVBL1 CSNK2A1 PDCD11 PRKDC | 1.65e-05 | 206 | 244 | 9 | 22174317 | |
| Pubmed | ACP2 CD109 SSR4 CLPX TRRAP ALKBH5 TUBA4A TUBA1B FASN PTPN12 TBC1D4 ECEL1 KPNA3 SMCHD1 PIR AP3M1 SACM1L CSNK2A1 ARHGEF1 PDCD11 ROBO1 PRKDC CTSD CPSF3 | 1.67e-05 | 1297 | 244 | 24 | 33545068 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | INTU KIF1A SPEG SLC5A7 GCKR STRN IMP4 ECEL1 NRBP1 DHX57 FREM3 C2orf81 THAP4 | 1.69e-05 | 442 | 244 | 13 | 15815621 |
| Pubmed | 1.75e-05 | 77 | 244 | 6 | 10835267 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.79e-05 | 208 | 244 | 9 | 33230847 | |
| Pubmed | ACTA1 MTMR1 PFAS SSR4 CLPX BLM TUBA1B PTPN12 TBC1D4 PI4KA PPP1R37 KPNA3 CCDC22 MINK1 CEP192 HUWE1 NHSL1 FAM171A2 CSNK2A1 ROBO1 CPSF3 | 1.85e-05 | 1049 | 244 | 21 | 27880917 | |
| Pubmed | 1.86e-05 | 8 | 244 | 3 | 20147394 | ||
| Pubmed | 1.86e-05 | 8 | 244 | 3 | 23260110 | ||
| Pubmed | 1.86e-05 | 8 | 244 | 3 | 20096780 | ||
| Interaction | TOP3B interactions | USP34 HDAC4 UBE4B SPEG OBSCN MED14 SPIRE1 PFAS EXTL3 ATG2A CLPX TRRAP RYR1 MAP3K5 NOD2 KMT2C FASN MGAT1 PSME4 PI4KA NADK ZC3H7B IQGAP3 MOCS2 BAHCC1 GPI UBE3B DHX57 CEP192 HUWE1 MLXIP MAPKAPK5 TRAK1 NHSL1 CELSR2 MEGF8 CTDP1 CIAO2B PDCD11 PRKDC | 4.70e-07 | 1470 | 236 | 40 | int:TOP3B |
| Interaction | YWHAZ interactions | CDK17 HDAC4 SPEG ACTA1 ACTC1 MTMR1 SPIRE1 PFAS GCKR MAP3K5 STRN TBC1D4 TUBA1A SRGAP3 NADK PUM3 KATNIP NCAPD3 WDR7 PARP8 MINK1 ROR2 OBSL1 CEP192 HUWE1 MLXIP MAPKAPK5 TRAK1 NHSL1 SLC9A1 FAM171A2 SIPA1L1 PRKAA1 TMEM102 USP54 MAP3K21 CTSD | 6.55e-07 | 1319 | 236 | 37 | int:YWHAZ |
| Interaction | TCP11L2 interactions | 3.69e-06 | 21 | 236 | 5 | int:TCP11L2 | |
| Interaction | ERRFI1 interactions | 4.71e-06 | 107 | 236 | 9 | int:ERRFI1 | |
| Interaction | NSUN5P1 interactions | 5.62e-06 | 59 | 236 | 7 | int:NSUN5P1 | |
| Interaction | ALKAL2 interactions | 5.67e-06 | 11 | 236 | 4 | int:ALKAL2 | |
| Interaction | YWHAQ interactions | CDK17 HDAC4 USP11 SPEG ACTA2 SPIRE1 GCKR MAP3K5 FASN TBC1D4 TUBA1A NADK NRBP1 PARP8 TUBA1C MINK1 ROR2 OBSL1 CEP192 MLXIP MAPKAPK5 TRAK1 NHSL1 IARS2 FAM171A2 CSNK2A1 SIPA1L1 TMEM102 PRKDC USP54 MAP3K21 | 7.42e-06 | 1118 | 236 | 31 | int:YWHAQ |
| Interaction | YWHAG interactions | CDK17 HDAC4 SPEG ACP2 ACTC1 SPIRE1 TRRAP TUBA4A MAP3K5 TBC1D4 PI4KA NADK KDR NRBP1 PARP8 MINK1 ROR2 CEP192 HUWE1 MLXIP MAPKAPK5 TRAK1 NHSL1 IARS2 FAM171A2 MAP4K5 ARHGEF1 SIPA1L1 TMEM102 PRKDC USP54 MAP3K21 CPSF3 | 9.85e-06 | 1248 | 236 | 33 | int:YWHAG |
| Interaction | TRIM9 interactions | 1.07e-05 | 90 | 236 | 8 | int:TRIM9 | |
| Interaction | CDHR4 interactions | 1.46e-05 | 68 | 236 | 7 | int:CDHR4 | |
| Interaction | SSR2 interactions | 1.53e-05 | 46 | 236 | 6 | int:SSR2 | |
| Interaction | ATOH1 interactions | 4.25e-05 | 80 | 236 | 7 | int:ATOH1 | |
| Interaction | YWHAB interactions | CDK17 HDAC4 SPEG ACTA2 ACTC1 SPIRE1 GCKR TRRAP MAP3K5 TBC1D4 NADK NRBP1 NCAPD3 PARP8 MINK1 ROR2 CEP192 MLXIP TRAK1 NHSL1 SLC9A1 FAM171A2 CSNK2A1 SIPA1L1 PRKAA1 USP54 MAP3K21 | 6.04e-05 | 1014 | 236 | 27 | int:YWHAB |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | SOCS7 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 3.23e-11 | 149 | 244 | 12 | chr17q12 |
| Cytoband | 17q12 | 1.57e-05 | 99 | 244 | 6 | 17q12 | |
| GeneFamily | Actins | 1.24e-05 | 6 | 156 | 3 | 929 | |
| GeneFamily | Tubulins | 6.88e-05 | 26 | 156 | 4 | 778 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.83e-04 | 40 | 156 | 4 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 4.82e-04 | 160 | 156 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.00e-04 | 161 | 156 | 7 | 593 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 6.45e-04 | 20 | 156 | 3 | 1371 | |
| GeneFamily | Ubiquitin specific peptidases | 1.38e-03 | 56 | 156 | 4 | 366 | |
| GeneFamily | Class II Cys-based phosphatases|Acid phosphatases | 1.51e-03 | 7 | 156 | 2 | 1071 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP | USP34 FASN AGL GPI FSD2 DHX57 HUWE1 MED15 FBH1 SIPA1L1 PRKDC | 2.56e-06 | 200 | 240 | 11 | M7872 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | SHPK TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 6.76e-08 | 90 | 238 | 10 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | ACP2 TUBA4A KDR TBC1D3G TBC1D3K TBC1D3F COL6A1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.85e-05 | 281 | 238 | 13 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | ACP2 TUBA4A KDR TBC1D3G TBC1D3K TBC1D3F COL6A1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.85e-05 | 281 | 238 | 13 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | RBM12B OBSCN SRGAP3 PAN2 KATNIP RPRD2 UBE3B TRAK1 IARS2 MAP3K21 | 2.90e-08 | 166 | 244 | 10 | 32d2eaf8a5d03881bf74d680825af2d5110b082d |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.36e-07 | 178 | 244 | 9 | 30d2b54462fd16222ad2e3806be6143e834b29e0 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-07 | 179 | 244 | 9 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.00e-06 | 113 | 244 | 7 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.00e-06 | 113 | 244 | 7 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.00e-06 | 113 | 244 | 7 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-06 | 174 | 244 | 8 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.68e-06 | 175 | 244 | 8 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.71e-06 | 179 | 244 | 8 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.54e-06 | 185 | 244 | 8 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.54e-06 | 185 | 244 | 8 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 190 | 244 | 8 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 190 | 244 | 8 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.21e-05 | 194 | 244 | 8 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 195 | 244 | 8 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.30e-05 | 196 | 244 | 8 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-05 | 196 | 244 | 8 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.35e-05 | 197 | 244 | 8 | 46d8c7e9b3aff70bc58894282d0ec9e87d37235f | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.35e-05 | 197 | 244 | 8 | 1a82e0e74fc5fd71c490d98e8813d719b0b81aa6 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-05 | 200 | 244 | 8 | 37d9f46f727a31e8e94e348e4ddd71a2125ba01a | |
| ToppCell | proximal-mesenchymal-Fibromyocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-05 | 200 | 244 | 8 | 49658e1b530de0dad16d45a1112bdf5329bb800d | |
| ToppCell | proximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-05 | 200 | 244 | 8 | ed6fbe61a04d29b105054f7058abe7469314b304 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.93e-05 | 150 | 244 | 7 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-05 | 153 | 244 | 7 | 991782d111d66e25b40319d4e6dea40f2c2c0805 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.48e-05 | 156 | 244 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.04e-05 | 161 | 244 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 168 | 244 | 7 | 55c9de7b3a1d6cf7b02b020ff92ab4ede8d195cc | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 171 | 244 | 7 | 159ce6d5513008532dd7785b915b3fe7440cc4b2 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.55e-05 | 177 | 244 | 7 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.55e-05 | 177 | 244 | 7 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.95e-05 | 179 | 244 | 7 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 5.95e-05 | 179 | 244 | 7 | 83506e00fe99b6450efd2f13f716926a0a4b03cd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-05 | 180 | 244 | 7 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-05 | 180 | 244 | 7 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 182 | 244 | 7 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-05 | 184 | 244 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-05 | 184 | 244 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 7.08e-05 | 184 | 244 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-05 | 184 | 244 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 185 | 244 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.84e-05 | 187 | 244 | 7 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.84e-05 | 187 | 244 | 7 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.10e-05 | 188 | 244 | 7 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-05 | 188 | 244 | 7 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 8.38e-05 | 189 | 244 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-05 | 189 | 244 | 7 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 190 | 244 | 7 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-05 | 190 | 244 | 7 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.94e-05 | 191 | 244 | 7 | 7235a4d1601c88a2c8af571a2c04ab56d32f1b9a | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.94e-05 | 191 | 244 | 7 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 8.94e-05 | 191 | 244 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 192 | 244 | 7 | 9e031bf93eb8757fdd0cc22f01b44e48f85532d5 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.24e-05 | 192 | 244 | 7 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.24e-05 | 192 | 244 | 7 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.54e-05 | 193 | 244 | 7 | e7012f7b53971972299db34fa51ff51a4e4987fe | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-05 | 193 | 244 | 7 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 9.54e-05 | 193 | 244 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 194 | 244 | 7 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 194 | 244 | 7 | 6e12a7da35be4c0ecf998ef94b8989b89d74b200 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-05 | 194 | 244 | 7 | d602a0cdb69cd5a3e9ef61ddbab8d920557dd73e | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 194 | 244 | 7 | c52f10140c66e8c0566421c3d535d5d92bf595e1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-05 | 194 | 244 | 7 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 194 | 244 | 7 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 194 | 244 | 7 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 1.02e-04 | 195 | 244 | 7 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.04e-04 | 136 | 244 | 6 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 196 | 244 | 7 | a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 196 | 244 | 7 | 476812fc1422aca8010d771eff11fa6081f15a2d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 197 | 244 | 7 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 197 | 244 | 7 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 198 | 244 | 7 | d91bd26e499637949768587603cad3c03dcc56e7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 198 | 244 | 7 | 8de49c62ab533031936db4cee50ff13b259ecc22 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 198 | 244 | 7 | 60e5bd8dfe27c43ce5f4da19b65270c41577ef4f | |
| ToppCell | distal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-04 | 198 | 244 | 7 | 9d1d95e7703cfc70a8ad427e400c340dbd205db8 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 198 | 244 | 7 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 198 | 244 | 7 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 198 | 244 | 7 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-04 | 198 | 244 | 7 | f5a12861e2b8ff8309f3e4d0ad83d4f6860cc616 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 198 | 244 | 7 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | distal-mesenchymal-Fibromyocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-04 | 198 | 244 | 7 | fbfac1d10e4224990a094cc84b74bbc206881423 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.15e-04 | 199 | 244 | 7 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 1.19e-04 | 200 | 244 | 7 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-CD16+_Monocyte|ICU-NoSEP / Disease, condition lineage and cell class | 1.19e-04 | 200 | 244 | 7 | f661e1737be736c62ffb04a45667a65fc3d11e2a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.19e-04 | 200 | 244 | 7 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Macroglial|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.19e-04 | 200 | 244 | 7 | bda719369aa199902789061e223b129f70a1317a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 200 | 244 | 7 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-Dividing_AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 200 | 244 | 7 | befc25cbcbac2c02e5fd33d6e78e59979050090c | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 140 | 244 | 6 | eb1d22f5f5dbf60b6485464baec4be9b3060f65c | |
| Drug | NSC3096 | ACTA1 ACTA2 SLC5A7 ACTC1 TUBA4A BLM TUBA1A TUBA1C MED15 RUVBL1 | 6.89e-08 | 98 | 234 | 10 | CID000002832 |
| Drug | 5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA | USP34 TMEM165 ACTA2 MTMR1 ZC3H7B BAHCC1 STRN3 CCDC22 UBE3B MINK1 MAP4K5 ZNF552 | 9.97e-07 | 197 | 234 | 12 | 834_DN |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 4.25e-06 | 4 | 234 | 3 | DB07574 | |
| Drug | Epothilone D | 5.05e-06 | 12 | 234 | 4 | DB01873 | |
| Drug | Epothilone B | 5.05e-06 | 12 | 234 | 4 | DB03010 | |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | MAOA NOD2 SHPK SPON2 NADK HEMK1 CCDC22 TRMO SIPA1L1 ZNF552 CTSD | 5.65e-06 | 194 | 234 | 11 | 1146_UP |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A | MTMR1 GCKR KLHL29 SHPK PPP1R37 FKBP1A AOX1 BCO1 PLEKHG6 PDCD11 SMPD1 | 6.23e-06 | 196 | 234 | 11 | 5947_DN |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | USP34 UBE4B SPEG KATNIP MINK1 TRMO TRAK1 AOPEP ARHGEF1 ZNF552 CTSD | 6.23e-06 | 196 | 234 | 11 | 7391_DN |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; HL60; HG-U133A | USP34 ACP2 TRRAP TBC1D4 SPON2 RPRD2 NRBP1 MLXIP RUVBL1 MAP4K5 CSNK2A1 | 6.54e-06 | 197 | 234 | 11 | 1780_DN |
| Drug | CID5288653 | 8.90e-06 | 28 | 234 | 5 | CID005288653 | |
| Drug | tropone | 1.50e-05 | 31 | 234 | 5 | CID000010881 | |
| Drug | NSC 89199 | 1.89e-05 | 54 | 234 | 6 | CID000003268 | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HT_HG-U133A | 3.43e-05 | 194 | 234 | 10 | 6705_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | MTMR1 WDR25 ITGA7 PGAP6 SRGAP3 NADK FKBP1A COL6A1 SLC9A1 ARHGEF1 | 3.58e-05 | 195 | 234 | 10 | 4333_DN |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.58e-05 | 195 | 234 | 10 | 3327_UP | |
| Drug | Suramin sodium salt; Up 200; 10uM; PC3; HT_HG-U133A | MED14 SHPK NADK ZC3H7B DOP1B BAHCC1 COL6A1 DDX60 MINK1 SMPD1 | 3.91e-05 | 197 | 234 | 10 | 7529_UP |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; HL60; HG-U133A | ACP2 MGAT1 TBC1D4 PUM3 HEMK1 FKBP1A RUVBL1 CSNK2A1 CTDP1 PDCD11 | 3.91e-05 | 197 | 234 | 10 | 1589_DN |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; HL60; HG-U133A | 4.08e-05 | 198 | 234 | 10 | 1574_UP | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | HDAC4 MED14 BMPR2 PTPN12 KATNIP MINK1 HIPK3 LRP2 ZNF552 SMPD1 | 4.26e-05 | 199 | 234 | 10 | 1483_DN |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; HL60; HT_HG-U133A | KIF1A ITGA7 MAP3K5 BMPR2 RPRD2 UBE3B MINK1 PIR SLC9A1 SIPA1L1 | 4.26e-05 | 199 | 234 | 10 | 1270_UP |
| Drug | oryzalin | 4.60e-05 | 63 | 234 | 6 | CID000029393 | |
| Disease | microlissencephaly (implicated_via_orthology) | 2.13e-07 | 8 | 222 | 4 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 2.13e-07 | 8 | 222 | 4 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 2.13e-07 | 8 | 222 | 4 | DOID:0080918 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | HDAC4 MAOA AVPR2 CYP24A1 ACTA2 CD109 OBSCN MED14 RXRB FASN BMPR2 SRGAP3 AFF1 KDR ADGRF4 DLEC1 GPI SLC7A7 TEK SIPA1L1 PRKAA1 ROBO1 USP54 CPSF3 PCDH8 | 6.28e-07 | 1074 | 222 | 25 | C0006142 |
| Disease | lissencephaly (implicated_via_orthology) | 1.63e-06 | 27 | 222 | 5 | DOID:0050453 (implicated_via_orthology) | |
| Disease | insulin-like growth factor-binding protein 1 measurement | 4.16e-06 | 5 | 222 | 3 | EFO_0020474 | |
| Disease | valine measurement | 1.22e-05 | 40 | 222 | 5 | EFO_0009792 | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 1.44e-05 | 7 | 222 | 3 | EFO_0801657 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.76e-05 | 43 | 222 | 5 | EFO_0022254 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 2.29e-05 | 8 | 222 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 2.29e-05 | 8 | 222 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 2.29e-05 | 8 | 222 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 2.29e-05 | 8 | 222 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in small HDL percentage | 4.08e-05 | 51 | 222 | 5 | EFO_0022240 | |
| Disease | intestinal atresia (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 4.85e-05 | 10 | 222 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | total phospholipids in lipoprotein particles measurement | 4.93e-05 | 53 | 222 | 5 | EFO_0022315 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 4.93e-05 | 53 | 222 | 5 | EFO_0022286 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.16e-05 | 127 | 222 | 7 | EFO_0008595, EFO_0020947 | |
| Disease | 1-myristoylglycerol (14:0) measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0800252 | |
| Disease | complement component C1q receptor measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0802427 | |
| Disease | coagulation factor IX measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0020263 | |
| Disease | 1-carboxyethylisoleucine measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0800105 | |
| Disease | 1-carboxyethylleucine measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0800104 | |
| Disease | 1-carboxyethylphenylalanine measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0800101 | |
| Disease | X-19438 measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0800801 | |
| Disease | leptin measurement, HOMA-IR | 5.64e-05 | 2 | 222 | 2 | EFO_0004501, EFO_0005000 | |
| Disease | X-24295 measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0800869 | |
| Disease | glucose-to-mannose ratio | 5.64e-05 | 2 | 222 | 2 | EFO_0021404 | |
| Disease | mannose measurement, blood metabolite measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0005664, EFO_0006958 | |
| Disease | leptin measurement, fasting blood insulin measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0004466, EFO_0005000 | |
| Disease | glucokinase regulatory protein measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0020406 | |
| Disease | inhibin beta A chain measurement | 5.64e-05 | 2 | 222 | 2 | EFO_0020469 | |
| Disease | cholesterol to total lipids in large LDL percentage | 6.44e-05 | 56 | 222 | 5 | EFO_0022235 | |
| Disease | Hypertrophic Cardiomyopathy | 7.02e-05 | 57 | 222 | 5 | C0007194 | |
| Disease | triglycerides to total lipids in small LDL percentage | 8.29e-05 | 59 | 222 | 5 | EFO_0022337 | |
| Disease | Congenital muscular dystrophy | 8.79e-05 | 12 | 222 | 3 | cv:C0699743 | |
| Disease | free cholesterol in VLDL measurement | 9.73e-05 | 61 | 222 | 5 | EFO_0022276 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 1.44e-04 | 14 | 222 | 3 | OBA_2045143 | |
| Disease | familial hyperlipidemia | 1.55e-04 | 106 | 222 | 6 | MONDO_0001336 | |
| Disease | follistatin-related protein 3 measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0020394 | |
| Disease | tubulointerstitial nephritis antigen-like measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0803197 | |
| Disease | EGF-containing fibulin-like extracellular matrix protein 1 measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0022022 | |
| Disease | mannonate measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0800971 | |
| Disease | level of Phosphatidylethanolamine (18:0_0:0) in blood serum | 1.68e-04 | 3 | 222 | 2 | OBA_2045138 | |
| Disease | level of Diacylglycerol (18:1_18:3) in blood serum | 1.68e-04 | 3 | 222 | 2 | OBA_2045172 | |
| Disease | percent glycated albumin | 1.68e-04 | 3 | 222 | 2 | EFO_0009304 | |
| Disease | level of Phosphatidylcholine (16:0_0:0) in blood serum | 1.68e-04 | 3 | 222 | 2 | OBA_2045066 | |
| Disease | tumor necrosis factor receptor superfamily member 1B measurement | 1.68e-04 | 3 | 222 | 2 | EFO_0010624 | |
| Disease | level of Phosphatidylcholine (17:0_18:1) in blood serum | 1.68e-04 | 3 | 222 | 2 | OBA_2045085 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.70e-04 | 37 | 222 | 4 | EFO_0007645, EFO_0009458 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.70e-04 | 37 | 222 | 4 | EFO_0022252 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.75e-04 | 69 | 222 | 5 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.79e-04 | 15 | 222 | 3 | C3645536 | |
| Disease | cathepsin D measurement | 1.79e-04 | 15 | 222 | 3 | EFO_0010611 | |
| Disease | diacylglycerol 44:7 measurement | 2.19e-04 | 16 | 222 | 3 | EFO_0020069 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 2.64e-04 | 17 | 222 | 3 | EFO_0004626, EFO_0004627 | |
| Disease | Moyamoya Disease | 2.64e-04 | 17 | 222 | 3 | C0026654 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 2.64e-04 | 17 | 222 | 3 | OBA_2045063 | |
| Disease | urate measurement, bone density | UBE4B MEX3C ARHGAP22 STRN USH2A DNAH8 UMAD1 WDR7 THAP4 MAP4K5 CSNK2A1 ROBO1 PRKDC KCNH5 | 2.72e-04 | 619 | 222 | 14 | EFO_0003923, EFO_0004531 |
| Disease | triglycerides in large LDL measurement | 3.06e-04 | 43 | 222 | 4 | EFO_0022319 | |
| Disease | Congenital Fiber Type Disproportion | 3.15e-04 | 18 | 222 | 3 | C0546264 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.17e-04 | 121 | 222 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | palmitoleoyl-protein carboxylesterase NOTUM measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0802842 | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 3.35e-04 | 4 | 222 | 2 | C0410204 | |
| Disease | 1-carboxyethylvaline measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0800103 | |
| Disease | myristoyl-linoleoyl-glycerol (14:0/18:2) [1] measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0800527 | |
| Disease | urinary sodium to creatinine ratio | 3.35e-04 | 4 | 222 | 2 | EFO_0009883 | |
| Disease | lysophosphatidylcholine 16:0 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0010357 | |
| Disease | signal peptide, CUB and EGF-like domain-containing protein 1 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0803074 | |
| Disease | 1-palmitoleoylglycerol (16:1) measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0800398 | |
| Disease | MANSC domain-containing protein 1 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0801784 | |
| Disease | level of Triacylglycerol (51:4) in blood serum | 3.35e-04 | 4 | 222 | 2 | OBA_2045164 | |
| Disease | level of Diacylglycerol (16:1_18:1) in blood serum | 3.35e-04 | 4 | 222 | 2 | OBA_2045169 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0800411 | |
| Disease | ANGPTL8 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0020861 | |
| Disease | Gastric Adenocarcinoma | 3.65e-04 | 45 | 222 | 4 | C0278701 | |
| Disease | caffeine metabolite measurement | 3.72e-04 | 19 | 222 | 3 | EFO_0007872 | |
| Disease | esterified cholesterol measurement | 4.29e-04 | 128 | 222 | 6 | EFO_0008589 | |
| Disease | phospholipids in medium LDL measurement | 5.07e-04 | 49 | 222 | 4 | EFO_0022183 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 5.48e-04 | 50 | 222 | 4 | EFO_0022334 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | coagulation factor IXAB measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0020264 | |
| Disease | leptin receptor measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0004635 | |
| Disease | palmitoleoyl-linoleoyl-glycerol (16:1/18:2) [1] measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0800504 | |
| Disease | serum alpha-1-antitrypsin measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0005415 | |
| Disease | 1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0800454 | |
| Disease | 1-myristoyl-2-linoleoyl-GPC (14:0/18:2) measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0800452 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 5.55e-04 | 5 | 222 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (15:0_18:1) in blood serum | 5.55e-04 | 5 | 222 | 2 | OBA_2045064 | |
| Disease | progranulin measurement | 5.82e-04 | 22 | 222 | 3 | EFO_0004625 | |
| Disease | triacylglycerol 48:3 measurement | 5.82e-04 | 22 | 222 | 3 | EFO_0010406 | |
| Disease | triacylglycerol 54:6 measurement | 5.82e-04 | 22 | 222 | 3 | EFO_0010424 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 5.91e-04 | 51 | 222 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | triglycerides to total lipids in large LDL percentage | 5.91e-04 | 51 | 222 | 4 | EFO_0022331 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 5.91e-04 | 51 | 222 | 4 | EFO_0022242 | |
| Disease | total lipids in LDL measurement | 6.36e-04 | 52 | 222 | 4 | EFO_0022308 | |
| Disease | phospholipids in large LDL measurement | 6.84e-04 | 53 | 222 | 4 | EFO_0022174 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 6.84e-04 | 53 | 222 | 4 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 6.84e-04 | 53 | 222 | 4 | EFO_0022258 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSDVPFTLAPHVLAV | 86 | C9J7I0 | |
| PTFHRILLDTRFELP | 116 | Q9UPW8 | |
| STVEELHEPIPSLFR | 91 | Q9GZX9 | |
| LHEPIPSLFRALTEG | 96 | Q9GZX9 | |
| LVLSPDAPDRATHLI | 671 | Q9Y5B0 | |
| REALFPVHSVATPIF | 2166 | Q9P281 | |
| HSFLEKTAVLRVPVP | 101 | Q92888 | |
| FVGRLPVVVPLHSLD | 496 | O76031 | |
| QTSEFIRALKPPHVI | 401 | Q9UKF6 | |
| LRVAPEEHPTLLTEA | 96 | P68133 | |
| RLIHLSTAPEASLPA | 1376 | O14514 | |
| PGAPVSRILFLTDLH | 196 | P17405 | |
| DPIHIFERPIVSVSF | 206 | Q6P6C2 | |
| SRLSVAAPSIPLHIL | 106 | Q8IZF3 | |
| PLHILDFRAPETIES | 116 | Q8IZF3 | |
| LRVAPEEHPTLLTEA | 96 | P62736 | |
| RPTSFFIEDILLHKP | 16 | Q3C1V8 | |
| LRIFSRQDTHVSPPL | 201 | O95841 | |
| LGAHPFSRLDVLIVP | 431 | Q8N6M6 | |
| IASSSVLFRPIHPVG | 1256 | Q9HCU4 | |
| IIPPHATLVFDVELL | 91 | P62942 | |
| LLRSQVPPFDSHEVA | 1431 | Q9Y4B4 | |
| QTEVPPLFVIEFLHR | 71 | Q9Y2T2 | |
| QKPFHASRLVVPELS | 161 | O60826 | |
| LRTPVVRPAHISAFL | 21 | O14521 | |
| VRPAHISAFLQDRPI | 26 | O14521 | |
| LLVAFPDLHRPTETQ | 541 | Q569K6 | |
| RPTFSPATLTVHLLE | 2066 | Q9H251 | |
| HFPVPSTRVVLREVS | 1411 | Q2TAZ0 | |
| FHPVIISPDRIEELS | 281 | Q06278 | |
| ISPSLTEAHVEPLFR | 141 | Q8IWA6 | |
| RDPHFILDVPLGVIS | 141 | Q13613 | |
| PVDIRHFFTGLTIPD | 16 | Q8IXT5 | |
| APAPETREHLFKVLV | 16 | Q13637 | |
| LFPVPKDDSHRVITF | 206 | Q96G21 | |
| VLLYLLSPRDPAHTV | 441 | Q15397 | |
| LHVLSSSRSILEDPP | 386 | Q9NVM9 | |
| EPPRSATATLHVLLV | 651 | Q9Y5E7 | |
| EPPRSATATLHVLLV | 596 | Q96TA0 | |
| PIVLPTEHRALFGTD | 171 | Q7Z419 | |
| TLTAKIHFRPELPAE | 276 | P21397 | |
| QTEVPPLFVIEFLHR | 71 | P53677 | |
| RHEAITFNVILAEPP | 1156 | O75147 | |
| RAITPLQVHVDPAFL | 276 | Q504Q3 | |
| LQVHVDPAFLRFIPT | 281 | Q504Q3 | |
| HFIPGTTDPAVILDL | 166 | Q5JU00 | |
| LVTTEPIPVIFHRIA | 76 | Q8N3A8 | |
| IDSGVVPFLVPLLSH | 281 | O00505 | |
| SVVAAFSDLLHVRIP | 4096 | Q8NEZ4 | |
| PSIPAETSLAHRLVA | 321 | P56524 | |
| VQFPHESSPRARLLI | 86 | Q8IW41 | |
| DPHFVVDFPLSRLTV | 681 | Q86UX2 | |
| LHYRPSAELFPIIVS | 126 | P26572 | |
| IFLEVDPRHPELVSS | 291 | Q9Y5R4 | |
| RDFHLLVLTPPSVLG | 1426 | Q8NDA2 | |
| LIPFSPGLDHVVTIR | 1286 | O60303 | |
| FPLLAHAAVSVRPVL | 111 | Q9Y3R5 | |
| VTLSIPVDHPVRKLF | 696 | Q8NCM2 | |
| PELRGHFPLSITLVL | 1356 | Q8IY21 | |
| PSRPRTTEDLFAAIH | 1351 | Q5SYE7 | |
| HSLSFRPIVVPAGVE | 351 | O95544 | |
| HIPILQSRFIAPAAS | 96 | P53370 | |
| TVRLAEPHSPFRVEL | 171 | O95206 | |
| TTEPHDRFPITLLQT | 3996 | Q96JB1 | |
| SHFVLIAGEPLREPV | 236 | O00625 | |
| HIRARFPPTTAVSAI | 396 | Q96RN5 | |
| IEAPSPQHRILLDFL | 61 | Q7Z7M0 | |
| PLRLLIFATAHSPIG | 336 | P63132 | |
| VRQVFSELPFPSHVL | 1446 | Q9P1Y6 | |
| FPVVVHSVTPSLRDF | 496 | P42356 | |
| HSVTPSLRDFLVIPS | 501 | P42356 | |
| AAVSAPVLALHRLSP | 171 | Q969F8 | |
| VLDHTRPTALTSPEL | 341 | O94953 | |
| SHLLQVLPAERSLFP | 351 | Q0VF49 | |
| HFRTTPLEKNAPVLL | 306 | P06744 | |
| VLLITDIRHPVVNFP | 191 | P36915 | |
| ALPHPFAITIFEDTI | 3406 | P98164 | |
| LGPRIHALPESVSIF | 476 | Q00537 | |
| AEITVHFRSGAPPVI | 96 | Q9HCN3 | |
| PHVLAFRVSIARLAP | 111 | Q32M88 | |
| PPLSSSISVILHIRD | 426 | Q9Y5G0 | |
| RSPIVLHFPLVNRTF | 756 | Q68DD2 | |
| VSSAVRIDHAPDLPR | 96 | Q8N3Z3 | |
| DLRITPAETLNHPFV | 511 | Q9H422 | |
| FFLVHATERESKPPV | 3886 | Q7Z6Z7 | |
| VVVLSEHLSPPFREA | 406 | O95672 | |
| DVSLPVAPRYHLLLV | 556 | Q86VI3 | |
| IIAQVLPHRDPALVF | 11 | Q8N485 | |
| RDALVHARLPSFAIP | 141 | O60244 | |
| PTARELLFHPALFEV | 316 | Q9UHY1 | |
| TPLLDHSAPFVARAL | 201 | O75864 | |
| IHLSLPVPSETRALT | 231 | A8MVW0 | |
| ESLLRAIHFPQPLSD | 536 | Q14397 | |
| ESLLPETPTVNHVRF | 76 | Q9ULD6 | |
| TRPEPHFTIVIIFES | 396 | Q96MD2 | |
| AEQAPHFLLRPTSIR | 106 | Q5VST9 | |
| FPLRHSSILTPSVVI | 131 | Q8NGF1 | |
| RLALTHGAPLVPIFS | 211 | Q3SYC2 | |
| VHTVPITEDRLLKFP | 141 | P11117 | |
| VHTVPVAEDKLLRFP | 141 | Q9BZG2 | |
| GRTPEFSTIIPHLVV | 556 | Q3KR16 | |
| IARAPGVPEFHSSIL | 616 | Q9HAP2 | |
| ETAERLLATHVSPPL | 231 | Q8N0W3 | |
| ATVLFPIRPTHLGEI | 816 | Q6YHK3 | |
| VKDPVSRTPALVFEH | 101 | Q8NEV1 | |
| PSEVLRHVFAFLPVE | 216 | Q8NFZ0 | |
| PAVVHIELFRKLPFS | 181 | Q92743 | |
| EALVPPAFRTLALRH | 416 | A8MY62 | |
| PDVRFVIHASLPKSV | 956 | P54132 | |
| AEPTLVNFHLKRSIP | 406 | P15169 | |
| LHSGTLVPSRELPIA | 496 | Q07973 | |
| VFSVAITPDHLEPRL | 186 | P12109 | |
| ITPDHLEPRLSIIAT | 191 | P12109 | |
| LASPPRDITVHSVLD | 326 | Q9P218 | |
| IDVSPKHVVFATIPR | 471 | P20853 | |
| STLAPIFRITLPVLH | 101 | Q10981 | |
| FSRLIEPPHTDSLRA | 1021 | Q6P158 | |
| AALVVPKPRVTEVHF | 481 | O43909 | |
| APASALVRIPLHKFT | 16 | P07339 | |
| LLVTLAAHLPAEFTP | 106 | P69905 | |
| AVLSSEPAEPLLVRH | 426 | Q96BT3 | |
| VSVLVRAISLLPSPH | 416 | Q53R41 | |
| PPHSFNRDETIIIAL | 141 | Q13873 | |
| ITFTLPPVHRLSKDV | 66 | Q9GZN8 | |
| VKDPVSRTPALVFEH | 101 | P68400 | |
| AAILLSSRPIVHLTP | 636 | O75578 | |
| IRPHATEEIKVLFIP | 1436 | Q8TEP8 | |
| HVLIPVFDLSGPSSL | 281 | Q8N6P7 | |
| LHVVSSSLRPLGPLF | 176 | Q6PEX3 | |
| FTHRIRIVQDTAPPL | 621 | Q8IWA5 | |
| NSRIRFLTTHPVLPD | 441 | A6NN90 | |
| FLTTHPVLPDVARSR | 446 | A6NN90 | |
| LHPVSARARVFIELP | 836 | Q13683 | |
| PTVLPLSAHEARRYI | 376 | Q5T1A1 | |
| LYLPTRVTAIHIDPA | 1046 | P49327 | |
| SVQSSERPLFLVHPI | 2236 | P49327 | |
| ERPLFLVHPIEGSTT | 2241 | P49327 | |
| VTPVSLLADPAFIRA | 206 | O15382 | |
| LAPGHAILVEVLFSP | 546 | Q9Y238 | |
| LRGVTLTHFSPEPLT | 326 | Q5VWM4 | |
| IFSRDAPTHLPSVDL | 1226 | Q5VT52 | |
| LSAQPEVHRFALPVL | 176 | Q9NTJ5 | |
| VSRARPELLQSHFIP | 3346 | P21817 | |
| PKQSSHIPVFIRILD | 466 | Q9ULB4 | |
| IFDLIRSINDPEHPL | 46 | Q9Y3D0 | |
| TDEPRLSASAPLVIH | 641 | O75309 | |
| LYPVPLVHRVAIVSE | 861 | Q12756 | |
| PTAERLLTHTFVAQP | 266 | Q9Y4K4 | |
| AVVTDFILLGLSHPP | 11 | Q8NGC3 | |
| SFADLPHRPLLVDLT | 1156 | Q8N4C8 | |
| AITILVPELRPHFSL | 1166 | Q99683 | |
| PLTELGLVRFPVHAA | 376 | P24347 | |
| DAPTHTLVLPFTLAV | 146 | P0C091 | |
| ISVPFALSHPAVADI | 201 | Q9GZV3 | |
| RVSRLNPEAHPLSFV | 331 | O75445 | |
| LAFHPVEPVLVTASE | 486 | Q13033 | |
| IRALAFHPIEPVLIT | 466 | O43815 | |
| SRLLLPFADQHVEIP | 411 | Q969S9 | |
| DHVSLESAFTVRPLP | 1131 | A6NHR9 | |
| HSLVSFVVRIVPSPD | 146 | Q9BUD6 | |
| LRVSFVDVHPDVIPV | 16 | O60522 | |
| PLALETARVSTPHLE | 216 | A6NJY1 | |
| SRPSSPVHVAFERLE | 111 | Q5TCX8 | |
| SHAPFIFILVVDPSI | 261 | Q17RQ9 | |
| VFHRLGLVPVSEASI | 121 | O96007 | |
| SPISFFERTPIGHLL | 1031 | O95255 | |
| FLHNRTTPDIRITVP | 671 | A1L4K1 | |
| HPVFFLTVPAVLTIT | 41 | Q6ZW05 | |
| PTFPESIEHPLARRV | 546 | Q5U5Q3 | |
| LVDHDNTSPLFRTPL | 581 | Q05209 | |
| LVTLPIAIFADTRPA | 176 | P31391 | |
| HLPAVSKVLPAFRES | 1241 | O43166 | |
| GITPVFEPRAVSHLV | 111 | Q9UHJ6 | |
| TLRSSGFPVHLLPDI | 216 | Q9UHJ6 | |
| IDPTLRPRQLSISHF | 286 | Q8WVM0 | |
| ALHRVEPSVFLPASK | 16 | P22891 | |
| ILDVIVRSFAPILPH | 826 | Q9NSE4 | |
| VRSFAPILPHLAEEV | 831 | Q9NSE4 | |
| RTVKSALEPPDFVHL | 581 | Q01974 | |
| TINDLVEPPEHRSFL | 181 | P60153 | |
| IVHETELPPLTAREA | 51 | B9A6J9 | |
| RAKDFIHDSLPPVLT | 501 | Q9H6W3 | |
| TLTITVLRPFHEASP | 1686 | Q6Q759 | |
| LIRKHSQLFTAPVPE | 341 | Q7Z5H3 | |
| RIPHFSSLPLDDQVI | 356 | P28702 | |
| PFLVAETPRARHTLD | 376 | Q13131 | |
| TSVPTLRRFAVPLHV | 351 | Q9HAY6 | |
| LRVAPEEHPTLLTEA | 96 | P68032 | |
| RTPEHFALVPLTESQ | 696 | P51825 | |
| PTFSVIESHPGTLLR | 491 | P42695 | |
| ILHPSDELTRVTPSL | 676 | Q9UPV9 | |
| TPDPFRRHDSITIVV | 216 | P37287 | |
| RHAFLELQRTLPSVP | 66 | Q7RTU0 | |
| IVHETELPPLTAREA | 51 | A6NDS4 | |
| IVHETELPPLTAREA | 51 | P0C7X1 | |
| LRGVTLTHFSPEPLT | 326 | Q5VXH5 | |
| ISHPRFVRTIPELSV | 1106 | Q14690 | |
| EAPVATLEVRFTPHA | 331 | Q9BU70 | |
| VPSPVLRILDHTAFS | 86 | Q9UID6 | |
| VVPGSTAPLEFLHIT | 591 | Q9HC29 | |
| VRSESDFPPVFHIKL | 2576 | Q15772 | |
| IIIHHEAIFPSPREL | 686 | O43295 | |
| TVNHLLIIFIDDSPP | 291 | Q9Y5W7 | |
| IVHETELPPLTAREA | 51 | A6NER0 | |
| VPILFASTVRRHPDK | 76 | Q6P1M0 | |
| SIIPPLFTVSVDHRG | 126 | P51571 | |
| SAHEIILDFIRSRPP | 336 | Q08AE8 | |
| PSLPRESQIFVISRH | 141 | A6NCQ9 | |
| ARLAEKFPVISVPHL | 321 | Q96RF0 | |
| RLSFAHPPSAEVEAI | 126 | O15067 | |
| SIILRHLLNSPTDPF | 1256 | O95155 | |
| IHVERFTPVPSLLFN | 351 | Q9UM01 | |
| ITKAPTLIRSFQPHE | 461 | Q8IV35 | |
| FLPHLPSLEIRENAI | 346 | Q9H0D6 | |
| FATLAAVAESLIPVP | 271 | Q8N9M5 | |
| SPHRIFPSLLVVVAL | 11 | P19634 | |
| VLPELAFPSSEHRRS | 961 | Q9Y4E1 | |
| ASHLILPRIPFADVK | 486 | P08922 | |
| IVHETELPPLTAREA | 51 | A0A087X179 | |
| FPPRIVEHPSDLIVS | 66 | Q9Y6N7 | |
| ARVEKIFTPAAPVHT | 66 | Q9HC07 | |
| VAIFTIHRILPPDSG | 406 | Q02763 | |
| ISPHVPEFTARILEK | 1526 | Q14997 | |
| APAAREVILVLSAPF | 76 | O60343 | |
| HRALESSIAPIVIFA | 316 | Q9Y265 | |
| FPRIAPIRAAESLHS | 356 | O14512 | |
| LRELLNPVVEFVSHP | 2451 | P78527 | |
| VPLSTLGPAVIIFHE | 306 | Q9HBF4 | |
| PALVTHLSTVTPERL | 261 | Q7Z3V4 | |
| ILSQHERLLPTEEPS | 226 | Q9H707 | |
| VVATLPIPVVFVLRH | 626 | Q9H1V8 | |
| IFPILFVEPNLTARH | 241 | Q8TEC5 | |
| HVPRAVFVDLEPTVI | 61 | Q71U36 | |
| IVHETELPPLTAREA | 51 | A0A087WVF3 | |
| EPSQRPTFSELVEHL | 1146 | P35968 | |
| TRDLPLSPDTTVVLH | 2711 | Q70CQ2 | |
| SSVLLAAVPAHPRLS | 541 | Q86VR7 | |
| SLALHPREPVFLAQT | 431 | Q64LD2 | |
| LTTIHFIPSIPDIFL | 396 | O60602 | |
| HVPRAVFVDLEPTVI | 61 | P68363 | |
| IVHETELPPLTAREA | 51 | Q6DHY5 | |
| IVHETELPPLTAREA | 51 | Q8IZP1 | |
| RPPAFITTIAKEVHR | 1266 | Q9Y4E6 | |
| SAIATPRIIELAHPR | 336 | P0DJG4 | |
| EPLIKFLTRHPSQTV | 1556 | Q9Y4A5 | |
| VPLPISHKRVLEVFF | 486 | P51784 | |
| HVPRAVFVDLEPTVI | 61 | Q9BQE3 | |
| IVHETELPPLTAREA | 51 | A0A087X1G2 | |
| DQHRLLKPTAVPSIF | 71 | Q8WY91 | |
| VLIFREIHASLVPGP | 226 | P30518 | |
| ASFRELEQPLEHPVT | 196 | Q13488 | |
| IVHETELPPLTAREA | 51 | A0A087WXS9 | |
| IVHETELPPLTAREA | 51 | Q6IPX1 | |
| HVPRAVFVDLEPTVI | 61 | P68366 | |
| SSLPVIHDPSVFLLG | 1456 | Q70EL1 | |
| PHVLDLLAPLDSSRT | 231 | Q9UGR2 | |
| SPGSVIIFRVSLDPH | 841 | P35573 | |
| AAELLAVVRLPFIHP | 516 | Q96CT2 | |
| EVLIPPHEVFLVTRF | 221 | Q96L15 |